Glutathione Supplements: What Works, What Doesn't, and What Actually Raises It

What Glutathione Does in Your Body

Glutathione is a tripeptide (three amino acids: cysteine, glycine, and glutamate) found in virtually every human cell. It is the body's primary endogenous antioxidant, and it participates in detoxification, DNA repair, immune signaling, and the recycling of other antioxidants like vitamins C and E.

Unlike supplemental antioxidants that you take from outside, glutathione is manufactured inside cells by a two-step enzymatic process. The rate-limiting step requires cysteine, which is why cysteine availability is the bottleneck for glutathione production. When cysteine is plentiful, cells can make all the glutathione they need. When it is scarce, glutathione levels fall.

Glutathione exists in two forms: reduced (GSH, the active form) and oxidized (GSSG, the spent form). A healthy cell keeps the GSH-to-GSSG ratio high. When that ratio drops, oxidative stress rises and the cell's ability to defend against damage declines. Studies often use this ratio as an oxidative stress marker; in a liposomal glutathione study, the oxidized-to-reduced ratio fell by 20% (Sinha et al., 2018).

Glutathione is also central to liver Phase II detoxification. Toxins, drug metabolites, and environmental chemicals are conjugated with glutathione to make them water-soluble and excretable. This is why glutathione depletion is a hallmark of acetaminophen overdose, and why NAC, which replenishes glutathione, is the standard hospital treatment for that emergency.

Why Glutathione Declines With Age

Blood and tissue glutathione levels decline measurably with aging, driven by reduced synthesis capacity, increased oxidative demand, and lower intake of precursor amino acids. This age-related decline is associated with higher susceptibility to oxidative damage and is observed in neurodegenerative conditions, liver disease, and weakened immune function.

A 2023 review in Ageing Research Reviews documents this decline in detail. Glutathione and the enzymes that depend on it, including glutathione peroxidase and glutathione S-transferase, drop in most tissues with age, and the decline correlates with rising oxidative stress markers (Lapenna et al., 2023). The review connects lower glutathione to several hallmarks of aging: mitochondrial dysfunction, chronic low-grade inflammation, impaired detoxification and blunted immune responses. Whether raising glutathione back to youthful levels reverses these changes, or simply accompanies slower aging, is still debated.

Two factors drive the decline. First, production slows: the rate-limiting enzyme for glutathione synthesis, glutamate-cysteine ligase, becomes less active with age. Second, demand rises: older cells generate more reactive oxygen species, especially in mitochondria, so glutathione is used up faster than it is replaced. The result is a widening gap between supply and demand that most people never notice until fatigue, slow recovery or frequent infections become the new normal.

The decline is not just about eating less cysteine. The enzymes that assemble glutathione, glutamate-cysteine ligase and glutathione synthetase, become less active with age. At the same time, the body's oxidative burden increases, meaning glutathione is used up faster. The net result is a widening gap between supply and demand that begins in middle age and accelerates.

This has driven strong commercial interest in glutathione supplementation. The logic is simple: if glutathione drops with age and low glutathione is associated with disease, then taking more glutathione should help. But biology is rarely that simple, and the story of oral glutathione supplementation is mostly a story of poor absorption.

The Absorption Problem With Oral Glutathione

The gut enzyme gamma-glutamyltransferase (GGT) breaks glutathione into its component amino acids before most of it can be absorbed intact. A 1992 pharmacokinetic study in seven volunteers found that a single 3 g oral dose of glutathione did not significantly raise plasma levels of glutathione, cysteine, or glutamate at any point over 270 minutes (Witschi et al., 1992). A 2025 pharmaceutical review estimated oral glutathione bioavailability at below one percent for the unmodified molecule (Yin et al., 2025).

The first randomized, double-blind, placebo-controlled trial tested 500 mg of oral glutathione twice daily for four weeks in 39 healthy adults. It found no significant change in any oxidative stress biomarker, including glutathione status itself (Allen & Bradley, 2011).

A longer and better-designed trial changed the picture slightly. Richie et al. gave 54 healthy adults either 250 mg or 1,000 mg of oral glutathione daily, or placebo, for six months. Both dose groups showed increases in blood glutathione and in buccal cell glutathione by six months, with the 1,000 mg group also showing a twofold increase in natural killer cell cytotoxicity compared to placebo (Richie et al., 2015). This is the study most supplement brands cite.

The Richie trial is real and peer-reviewed, but context matters. It took six months of daily dosing for the effect to show. The short-term trial saw nothing. The immune marker improvement was a secondary outcome. And the mechanism remains unclear: if GGT breaks glutathione apart in the gut, how did the six-month trial produce results? One hypothesis is that the liberated amino acids, particularly cysteine, served as raw material for cells to rebuild glutathione internally, which would mean the supplement worked as an expensive amino acid delivery system rather than as intact glutathione.

Liposomal Glutathione. Does the Delivery Method Change the Outcome?

Liposomal encapsulation wraps glutathione in a phospholipid bubble designed to survive the gut and deliver the molecule intact. A small trial found that liposomal glutathione at 500 and 1,000 mg per day for one month raised blood glutathione by 40 percent over baseline and increased natural killer cell function (Sinha et al., 2018). The result is promising but came from a single, small, industry-funded study.

The Sinha trial enrolled 12 adults at two dose levels (500 and 1,000 mg/day). There was no placebo arm. Blood glutathione rose at both doses within two weeks. Natural killer cell cytotoxicity increased over the month, more so at the higher dose (Sinha et al., 2018).

It is the best human data liposomal glutathione has, and it is one small open-label study with no placebo control. The difference between this and the Richie trial (which had a placebo arm and 54 participants for six months) is the difference between preliminary signal and reasonable evidence. Liposomal glutathione may well outperform plain oral glutathione, but the claim is ahead of what the data firmly support (Sinha et al., 2018) (Richie et al., 2015).

How glutathione is delivered matters in other ways too. A 2026 human pharmacokinetic study comparing an orally dissolving film with a standard tablet found a distinct absorption profile and a trend toward greater glutathione exposure with the film (Jung et al., 2026). It was a trend rather than a clear difference, but it adds to the evidence that formulation affects how much reaches the blood.

NAC — The Precursor Strategy That Bypasses the Problem

N-acetylcysteine (NAC) is a modified form of the amino acid cysteine that survives digestion, enters cells, is deacetylated to free cysteine, and then feeds directly into the glutathione synthesis pathway. It has decades of clinical use, including as the standard treatment for acetaminophen overdose, specifically because it replenishes depleted glutathione.

The logic is simple. Cysteine is the rate-limiting building block for glutathione. Supplying more of it lets cells make glutathione themselves, where it is needed, without relying on intact glutathione surviving digestion. A 2021 review describes NAC as a cysteine donor that helps replenish glutathione and summarizes its use across many conditions linked to oxidative stress (Raghu et al., 2021).

NAC is not glamorous. It has been available as a generic supplement and prescription mucolytic for decades, it smells like sulfur, and it costs a fraction of liposomal glutathione. But its mechanism for raising glutathione is better understood and more consistently demonstrated in human trials than any direct glutathione supplement.

In a 2021 pilot, eight older adults who took GlyNAC for 24 weeks had their glutathione deficiency corrected, and markers of oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance and endothelial dysfunction improved; these gains reversed within 12 weeks of stopping (Sekhar, 2021). The follow-up randomized trial (24 older adults vs. 12 young controls) confirmed the same pattern over 16 weeks and added improvements in waist circumference, blood pressure, physical function and several aging hallmarks (Kumar et al., 2023). The sample sizes are small, but the consistency across two studies and the reversal after withdrawal strengthen the case for NAC-based glutathione repletion in aging.

The typical supplemental dose in studies is 600–1,800 mg per day, split into two or three doses. At higher doses, some people experience nausea or digestive discomfort. For a detailed look at forms, dosing, and safety, see our full NAC supplement guide.

Glycine. The Other Precursor Most People Overlook

Cysteine gets most of the attention, but glycine is the other amino acid in the glutathione tripeptide, and there is growing evidence that glycine availability also limits glutathione synthesis, particularly in older adults. Supplementing both glycine and NAC together (a combination sometimes called GlyNAC) has shown the largest glutathione increases in preliminary aging research.

The GlyNAC approach pairs glycine with NAC because glycine is the other conditionally essential amino acid in the glutathione molecule. Older adults tend to have lower glycine availability than younger adults, and in both Baylor studies, glycine plus NAC raised glutathione further than NAC alone had in earlier research, suggesting that supplying both precursors removes a dual bottleneck (Kumar et al., 2023).

You do not need a branded supplement to try this. Glycine powder is inexpensive and mixes easily into water; pairing 1 to 3 g of glycine with 600 mg of NAC twice daily approximates the GlyNAC doses used in the trials. Glycine has a mildly sweet taste and is well tolerated; the main side effect is occasional soft stools at higher doses.

Work from Baylor College of Medicine has tested this precursor approach directly. In a placebo-controlled trial, older adults who took glycine plus NAC (GlyNAC) for 16 weeks had their glutathione deficiency corrected, with improvements in oxidative stress, mitochondrial function, insulin resistance, inflammation, physical function and several markers of aging, and the supplement was well tolerated (Kumar et al., 2023). The trial was small (24 older adults), so larger studies are needed.

Glycine supplementation on its own is inexpensive, well-tolerated, and has independent benefits for sleep quality and joint health. At 3–5 g per day, it is a practical addition to a glutathione support strategy.

Glutathione and Skin Lightening. The Evidence Is Thin

Glutathione is heavily marketed in Asia for skin lightening. In a 12-week randomized trial in healthy women, 250 mg/day of oral glutathione (reduced or oxidized form) reduced wrinkles at some sites and showed a trend toward better skin elasticity compared with placebo (Weschawalit et al., 2017). A 2016 review counted three randomized trials supporting skin lightening with oral or topical glutathione, but said treatment duration, how long the effect lasts and maintenance remain unanswered, and noted that the Philippine FDA has warned against off-label use for skin lightening (Sonthalia et al., 2016).

Glutathione can shift melanin production from eumelanin (darker pigment) to pheomelanin (lighter pigment) by inhibiting the enzyme tyrosinase. This mechanism is real in cell studies. Whether taking a pill changes skin color in a noticeable, lasting, and safe way is a separate question, and the trials have not convincingly answered it.

The dermatological community remains cautious. High-dose intravenous glutathione for skin lightening is popular in some markets but carries risks of kidney damage and Stevens-Johnson syndrome in case reports. Oral supplementation is safer but less likely to produce the effect people are paying for.

What Actually Raises Glutathione. A Practical Summary

The most reliable approaches, ranked by strength of evidence, are: NAC supplementation (well-studied precursor strategy), adequate dietary protein with sulfur-containing amino acids (cysteine from whey protein, eggs, and cruciferous vegetables), liposomal glutathione (promising but insufficiently studied), exercise (acutely raises glutathione demand and chronically upregulates synthesis), and adequate sleep and stress management (chronic stress depletes glutathione).

Diet deserves more credit than supplements for most people. Sulfur-containing amino acids from whey protein, eggs, poultry and fish supply the cysteine that glutathione synthesis depends on. Whey protein, in particular, is one of the richest sources of cysteine-containing peptides, and early research suggested it could raise tissue glutathione in animal models (Bounous, 2003). Cruciferous vegetables, including broccoli, Brussels sprouts and cabbage, contain sulforaphane, an isothiocyanate that activates the Nrf2 transcription factor and upregulates the enzymes cells use to make and recycle glutathione (de Figueiredo et al., 2015). A diet rich in these foods will not produce the same spike in blood glutathione that a supplement does, but it keeps the production machinery active across every cell rather than relying on whatever fraction of an oral dose survives digestion.

Exercise also raises glutathione, at least in the long run. Regular aerobic and resistance training upregulates antioxidant defenses, including glutathione synthesis, as an adaptation to the oxidative stress of each session. Sedentary older adults who start a training program typically see their baseline glutathione levels rise over weeks to months, reinforcing the idea that the decline with age is partly a disuse problem.

Plain oral glutathione at standard doses may contribute something over months of consistent use, based on the Richie trial, but it is not the most efficient route. S-acetyl glutathione is marketed as a more stable form, but human bioavailability data for it are essentially absent from the peer-reviewed literature.

For people interested in the NAD+ and glutathione stack that comes up in longevity discussions, the evidence for combining NMN with glutathione or NAC is mechanistically appealing (both address age-related cellular decline) but has not been tested in a controlled human trial as a combination. Our best NAD+ supplements guide discusses that stacking question in detail.

The bottom line: your body already has the machinery to make glutathione. The most evidence-based strategy is to feed that machinery the raw materials it needs, cysteine via NAC, glycine from food or supplements, adequate protein, and the cofactors (selenium, riboflavin, vitamin C) that keep the enzymes running. Buying pre-made glutathione in a capsule is skipping a step that biology does not let you skip easily.

Does oral glutathione actually work?

Results are mixed. A four-week trial at 1,000 mg per day found no effect. A six-month trial at 250 and 1,000 mg per day found modest increases in blood glutathione. The difference may be duration: it appears to take months of daily dosing. Whether any of this translates to meaningful health outcomes beyond lab markers is still unestablished (Allen & Bradley, 2011) (Richie et al., 2015).

Is liposomal glutathione worth the extra cost?

It may improve absorption over plain glutathione, based on one small study showing higher blood levels after a month. But the evidence is a single open-label trial with 12 participants and no placebo group. If budget is a factor, NAC at 600–1,200 mg per day achieves the same goal, raising intracellular glutathione, through a better-studied mechanism at a fraction of the price (Sinha et al., 2018).

What is the best way to increase glutathione naturally?

Eat adequate protein, especially from sources rich in cysteine (whey protein, eggs, poultry, cruciferous vegetables like broccoli and Brussels sprouts). Exercise regularly, which upregulates glutathione synthesis over time. Sleep enough, since chronic sleep deprivation depletes antioxidant reserves. If you supplement, NAC (600–1,200 mg per day) is the best-studied oral strategy for raising glutathione.

Is NAC better than glutathione supplements?

For the purpose of raising intracellular glutathione, NAC has more consistent evidence. It survives digestion, enters cells, and provides the rate-limiting amino acid cysteine that cells need to build glutathione themselves. Glutathione supplements face a fundamental absorption barrier that NAC does not.

Can you take glutathione and NAC together?

There is no known interaction that would make this unsafe. Whether it is useful is a different question. If NAC already provides the cysteine your cells need to make glutathione, adding pre-made glutathione on top may be redundant rather than additive. No trial has tested the combination against NAC alone.

Does glutathione lighten skin?

Small trials have reported modest melanin index reductions, but the evidence base is weak: small samples, short durations, and unclear clinical significance. Glutathione can shift melanin synthesis in cell models, but translating that to visible, lasting skin lightening from a pill is unproven. Intravenous glutathione for this purpose carries real safety risks and is not recommended.

How much glutathione should you take per day?

The six-month trial that showed increases in blood glutathione used 250 and 1,000 mg per day. There is no established RDA for glutathione supplementation. If you choose to supplement directly, 500–1,000 mg per day in liposomal form is the range with the most (limited) evidence. For the precursor approach, NAC at 600–1,200 mg per day is more reliably studied (Richie et al., 2015).